Clinical Trial Update: Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4) [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial comparing hyperfractionated radiotherapy to conventionally fractionated radiotherapy in standard-risk medulloblastoma has completed;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: Institut Curie | Conditions: Medulloblastoma | Phase 3 | Status: COMPLETED